Article
A new ATRX mutation in a patient with acquired α-thalassemia myelodysplastic syndrome.
Hemoglobin - 1 Jan 2012
Herbaux Charles, Badens Catherine, Guidez Stéphanie, Lacoste Caroline, Maboudou Patrice, Rose Christian
Abstract excerpt
Acquired α-thalassemia (α-thal) myelodysplastic syndrome (ATMDS) is a rare acquired syndrome characterized by a somatic point mutation in the ATRX gene in patients with chronic myeloid disorders. We describe the case of a 78-year-old man with myelodysplastic syndrome (MDS) and striking microcytic, hypochromic anemia. Brilliant cresyl blue supravital stain of the peripheral blood and hemoglobin (Hb)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
